GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Labgenomics Co 084650.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

1,872

-1.16%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩88.16bn

FY2016FY2025

Net income

−₩64.37bn

FY2016FY2025

Free cash flow

−₩32.20bn

FY2016FY2025

Shareholders' equity

₩149.62bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩88.16bn₩85.90bn₩71.08bn₩144.77bn₩202.41bn₩119.48bn₩33.18bn₩27.54bn₩24.81bn₩24.06bn
Gross profit₩30.64bn₩31.41bn₩36.25bn₩96.77bn₩125.41bn₩71.75bn₩13.39bn₩9.44bn₩9.46bn₩10.75bn
Research and development₩1.87bn₩2.68bn₩2.62bn₩1.86bn₩556.9m———₩350.6m₩350.6m
Operating income—−₩22.54bn−₩6.66bn₩66.21bn₩104.52bn₩53.27bn₩775.8m−₩3.23bn−₩2.94bn−₩8.5m
Net income−₩64.37bn−₩23.80bn−₩4.67bn₩48.40bn₩83.85bn₩42.77bn₩962.4m−₩3.97bn−₩3.44bn₩723.5m
Diluted earnings per share-7,092.28-2,621.66-514.945,332.039,238.494,711.67106.03-437.70-403.4879.71

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩230.15bn₩295.66bn₩313.46bn₩250.65bn₩204.29bn₩109.36bn₩49.48bn₩47.09bn₩39.87bn₩43.21bn
Cash and short-term investments—₩51.36bn₩115.39bn₩136.87bn₩98.90bn₩53.09bn₩14.06bn₩14.31bn₩6.66bn₩11.76bn
Total liabilities₩80.53bn₩79.35bn₩85.31bn₩41.32bn₩46.57bn₩27.82bn₩19.06bn₩16.99bn₩17.52bn₩18.17bn
Debt₩13.12bn₩2.87bn₩18.79bn₩20.20bn₩4.40bn₩4.20bn₩9.88bn₩9.35bn₩11.24bn₩11.87bn
Shareholders' equity₩149.62bn₩216.31bn₩227.80bn₩209.33bn₩157.72bn₩81.54bn₩30.42bn₩30.10bn₩22.35bn₩25.04bn
Shares outstanding9m9m9m9m9m9m9m9m9m9m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩30.54bn−₩12.99bn₩2.42bn₩69.87bn₩65.36bn₩46.37bn₩3.19bn₩608.0m−₩1.06bn₩2.54bn
Capital spending−₩1.66bn−₩4.55bn−₩5.20bn−₩38.33bn−₩13.72bn−₩699.2m−₩560.9m−₩2.03bn−₩4.30bn−₩4.08bn
Free cash flow−₩32.20bn−₩17.54bn−₩2.77bn₩31.54bn₩51.65bn₩45.67bn₩2.63bn−₩1.42bn−₩5.36bn−₩1.53bn
Dividends paid———−₩3.32bn——————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩15.75bn₩17.93bn₩20.92bn₩23.04bn₩22.30bn₩21.90bn₩22.10bn₩21.65bn
Gross profit₩4.60bn₩6.73bn₩6.09bn₩9.05bn₩7.03bn₩11.22bn₩8.13bn₩10.68bn
Operating income−₩6.87bn——−₩1.71bn−₩20.16bn−₩5.28bn−₩15.13bn−₩3.17bn
Net income−₩2.54bn−₩4.71bn−₩40.87bn−₩3.48bn−₩14.65bn−₩5.38bn−₩12.31bn−₩2.71bn
Diluted earnings per share-279.59-518.73-4,502.56-383.47-1,614.04-592.20-1,355.72-298.51
Cash from operations−₩3.59bn−₩8.54bn−₩6.95bn−₩6.41bn−₩6.58bn−₩10.58bn−₩12.99bn−₩9.13bn
Capital spending−₩521.0m−₩260.0m−₩843.0m−₩480.0m−₩210.0m−₩129.0m−₩4.55bn−₩4.31bn
Free cash flow−₩4.11bn−₩8.80bn−₩7.80bn−₩6.89bn−₩6.79bn−₩10.71bn−₩17.54bn−₩13.43bn
Total assets₩232.08bn₩234.96bn₩230.15bn₩264.67bn₩265.18bn₩288.79bn₩295.66bn₩295.29bn
Cash and short-term investments—————₩40.54bn₩51.36bn₩61.56bn
Debt₩22.41bn₩17.26bn₩13.12bn₩13.00bn₩13.00bn₩14.20bn₩2.87bn₩1.86bn
Shareholders' equity₩147.96bn₩149.16bn₩149.62bn₩188.67bn₩189.40bn₩210.87bn₩216.31bn₩218.63bn

Financial ratios

Data as of 8 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin34.8%36.6%51.0%66.8%62.0%60.1%———
Operating margin—-26.2%-9.4%45.7%51.6%44.6%3.3%——
Net margin-73.0%-27.7%-6.6%33.4%41.4%35.8%———
Return on equity-43.0%-11.0%-2.1%23.1%53.2%52.4%———
Return on assets-28.0%-8.0%-1.5%19.3%41.0%39.1%———
Free cash flow yield———————58.1%76.3%
Revenue growth2.6%20.9%-50.9%-28.5%69.4%260.1%———
Earnings growth170.5%409.1%-109.7%-42.3%96.1%4343.6%———
Current ratio1.24x1.78x2.47x8.77x4.20x3.50x———
Debt to equity0.09x0.00x0.07x0.09x0.02x0.03x———
Equity ratio65.0%73.2%72.7%83.5%77.2%74.6%———
Interest coverage—-4.09x-1.35x115.35x502.41x238.02x———
R&D as a share of sales2.1%3.1%3.7%1.3%0.3%———1.4%
Buybacks as a share of market value———————-6.6%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-15.2%-5.9%14.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin35.6%50.0%55.1%52.9%
Net margin-50.7%-11.4%11.5%9.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.3-4.8-37.43.02.33.340.5-11.9-21.5108.7
Price to sales0.91.32.51.00.91.21.21.73.03.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Dec 2021.

FY2022
Paid in the year250.00
  • 2-for-1 split · 7 Aug 2023
  • 3-for-1 split · 31 Mar 2022
  • 2-for-1 split · 15 Jun 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.